These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 22792175)
1. Cooperative interaction between the MUC1-C oncoprotein and the Rab31 GTPase in estrogen receptor-positive breast cancer cells. Jin C; Rajabi H; Pitroda S; Li A; Kharbanda A; Weichselbaum R; Kufe D PLoS One; 2012; 7(7):e39432. PubMed ID: 22792175 [TBL] [Abstract][Full Text] [Related]
2. Oncogenic MUC1-C promotes tamoxifen resistance in human breast cancer. Kharbanda A; Rajabi H; Jin C; Raina D; Kufe D Mol Cancer Res; 2013 Jul; 11(7):714-23. PubMed ID: 23538857 [TBL] [Abstract][Full Text] [Related]
4. MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression. Zaretsky JZ; Barnea I; Aylon Y; Gorivodsky M; Wreschner DH; Keydar I Mol Cancer; 2006 Nov; 5():57. PubMed ID: 17083744 [TBL] [Abstract][Full Text] [Related]
5. Rab31 expression levels modulate tumor-relevant characteristics of breast cancer cells. Grismayer B; Sölch S; Seubert B; Kirchner T; Schäfer S; Baretton G; Schmitt M; Luther T; Krüger A; Kotzsch M; Magdolen V Mol Cancer; 2012 Aug; 11():62. PubMed ID: 22920728 [TBL] [Abstract][Full Text] [Related]
6. Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer. Khodarev N; Ahmad R; Rajabi H; Pitroda S; Kufe T; McClary C; Joshi MD; MacDermed D; Weichselbaum R; Kufe D Oncogene; 2010 Feb; 29(6):920-9. PubMed ID: 19915608 [TBL] [Abstract][Full Text] [Related]
7. Inverse association of rab31 and mucin-1 (CA15-3) antigen levels in estrogen receptor-positive (ER+) breast cancer tissues with clinicopathological parameters and patients' prognosis. Kotzsch M; Kirchner T; Soelch S; Schäfer S; Friedrich K; Baretton G; Magdolen V; Luther T Am J Cancer Res; 2017; 7(9):1959-1970. PubMed ID: 28979817 [TBL] [Abstract][Full Text] [Related]
8. Targeting the intracellular MUC1 C-terminal domain inhibits proliferation and estrogen receptor transcriptional activity in lung adenocarcinoma cells. Klinge CM; Radde BN; Imbert-Fernandez Y; Teng Y; Ivanova MM; Abner SM; Martin AL Mol Cancer Ther; 2011 Nov; 10(11):2062-71. PubMed ID: 21862684 [TBL] [Abstract][Full Text] [Related]
9. Estrogenic effects of nonylphenol on pS2, ER and MUC1 gene expression in human breast cancer cells-MCF-7. Ren L; Marquardt MA; Lech JJ Chem Biol Interact; 1997 Apr; 104(1):55-64. PubMed ID: 9158695 [TBL] [Abstract][Full Text] [Related]
10. Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells. Alam M; Rajabi H; Ahmad R; Jin C; Kufe D Oncotarget; 2014 May; 5(9):2622-34. PubMed ID: 24770886 [TBL] [Abstract][Full Text] [Related]
11. The role of the small GTPase Rab31 in cancer. Chua CE; Tang BL J Cell Mol Med; 2015 Jan; 19(1):1-10. PubMed ID: 25472813 [TBL] [Abstract][Full Text] [Related]
12. MUC1-C oncoprotein activates ERK→C/EBPβ signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cells. Alam M; Ahmad R; Rajabi H; Kharbanda A; Kufe D J Biol Chem; 2013 Oct; 288(43):30892-903. PubMed ID: 24043631 [TBL] [Abstract][Full Text] [Related]
13. MUC1-C oncoprotein induces TCF7L2 transcription factor activation and promotes cyclin D1 expression in human breast cancer cells. Rajabi H; Ahmad R; Jin C; Kosugi M; Alam M; Joshi MD; Kufe D J Biol Chem; 2012 Mar; 287(13):10703-10713. PubMed ID: 22318732 [TBL] [Abstract][Full Text] [Related]
15. Rab31-dependent regulation of transforming growth factor ß expression in breast cancer cells. Soelch S; Beaufort N; Loessner D; Kotzsch M; Reuning U; Luther T; Kirchner T; Magdolen V Mol Med; 2021 Dec; 27(1):158. PubMed ID: 34906074 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of MUC1 predicts poor prognosis in patients with breast cancer. Jing X; Liang H; Hao C; Yang X; Cui X Oncol Rep; 2019 Feb; 41(2):801-810. PubMed ID: 30483806 [TBL] [Abstract][Full Text] [Related]
17. Interaction Between MUC1 and STAT1 Drives IFITM1 Overexpression in Aromatase Inhibitor-Resistant Breast Cancer Cells and Mediates Estrogen-Induced Apoptosis. Escher TE; Lui AJ; Geanes ES; Walter KR; Tawfik O; Hagan CR; Lewis-Wambi J Mol Cancer Res; 2019 May; 17(5):1180-1194. PubMed ID: 30655323 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of MUC1 expression by indole-3-carbinol. Lee IJ; Han F; Baek J; Hisatsune A; Kim KC Int J Cancer; 2004 May; 109(6):810-6. PubMed ID: 15027113 [TBL] [Abstract][Full Text] [Related]
19. Targeting the eIF4A RNA helicase blocks translation of the MUC1-C oncoprotein. Jin C; Rajabi H; Rodrigo CM; Porco JA; Kufe D Oncogene; 2013 Apr; 32(17):2179-88. PubMed ID: 22689062 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]